Notably, our findings suggest that certain MEC patients may not benefit from fractionated radiotherapy; in contrast, 2 Gy IR may stimulate radio-adaptive resistance through NFκB signaling. Here, NFKB1 is linked to mucoepidermoid carcinoma.